DAFTAR PUSTAKA

1. Rizzolia R, Boonenb S, Brandic ML, Burletd N, Delmase P, Reginster JY. The role of calcium and vitamin D in the management of osteoporosis. Bone. 2008; 42:246249. 2. Gehret C. Denosumab: a new therapy for osteoporosis. Pharmacotherapy Update. 2010 Jn/Feb; XIII(I): 1-9. 3. Peters BSE, Martini LA. Nutritional aspects of the prevention and treatment of osteoporosis. Arq Bras Endocrinol Metab. 2010; 54(2):179185. 4. Heaney RP. Calcium, dairy products and osteoporosis. Journal of the American College of Nutrition. 2000; 19(2):83S99S. 5. Scottish Intercollegiate Guidelines Network. Management of osteoporosis, A national clinical guideline. June 2003. 6. Hughes BD. Commentary: a revised clinicians guide to the prevention and treatment of osteoporosis. J Clin Endocrinol Metab. 2008 Jul; 93(7):24632465. 7. Jahari AB, Prihatini S. Risiko osteoporosis di Indonesia. Gizi Indon. 2007; 30(1):1-11. 8. Prihatini S, Mahirawati Vk, Jahari AB, Sudiman H. Faktor determinan risiko osteoporosis di tiga provinsi di indonesia. Media Litbang Kesehatan. 2010; XX(2):91-99. 9. Kawiyana IKS. Osteoporosis: patogenesis, diagnosis dan penanganan terkini. J Peny Dalam. 2009 Mei; 10(2):157-170. 10. Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, et al., editors. Harrisons principles of internal medicine. 16th ed. New York: McGraw Hill; 2005. 11. Metabolisme kalsium, fosfat, vitamin d,hormon thyroid, parathyroid serta pengaturannya di hipotalamus. [cited 2013 Jan 22]. Available from http://whydiawedha.blogspot.com/2010/07/metabolisme-kalsium-fosfatvitamin.html. 12. Patel1 VB, Vacek JL Graves L, Bhattacharya RK. Calcium affects on vascular endpoints. Nutrition & Metabolism. 2012;9:24.

13. Lerner UH. New molecules in the tumor necrosis factor ligand and receptor superfamilies with importance for physiological and pathological bone resorption. CROBM. 2004; 15:64. 14. Vega D, Maalouf NM, Sakhaee K. The role of receptor activator of nuclear factor-B (RANK)/RANK ligand/osteoprotegerin: clinical implications. The Journal of Clinical Endocrinology & Metabolism. 2007; 92(12):45144521. 15. Role of RANKL and RANK in bone loss and arthritis. Jones DH, Kong YY, Penninger JM. Ann Rheum Dis. 2002 ;61(Suppl II):ii32ii39. 16. Aubin JE, Bonnelye E. Osteoprotegerin and its ligand: a new paradigm for regulation of osteoclastogenesis and bone resorption [internet]. [Place unknown]: Medscape General Medicine; 2000 [cited 2013 Jan 2]. Available from: http://www.medscape.com. 17. Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocrine Reviews. 2000 Apr; 21(2):115137. 18. Houtkooper L, Farrell VA. Calcium supplement guidelines. The University of Arizona Cooperative Extension. 2004; 01(11):1-4. 19. Gonta P. Osteoporosis sebagai problematika klimakterium. Cermin Dunia Kedokteran. 1995; 112:25-28 20. Wark JD. Calcium supplementation: the bare bones. Australian Prescriber. 2003; 26(6):126-1267. 21. Suryono, Setiawan B, Martianto D, Sukandar D. Pengaruh pemberian susu terhadap kadar kalsium darah dan kepadatan tulang remaja pria. Media Gizi dan Keluarga. 2007 Jul; 31(1):63-70. 22. Davey DA. Calcium and the prevention and treatment of postmenopausal osteoporosis. SAMJ. 1997 Feb; 87(2):132-133. 23. Devine A, Prince RL, Bell R. Nutritional effect of calcium supplementation by skim milk powder or calcium tablets on total nutrient intake in postmenopausal women. Am J Clin Nutr. 1996; 64:731-7. 24. Kukuljan S, Nowson CA, Sanders KM, Nicholson GC, Seibel MJ, Salmon J, et al. Independent and combined effects of calcium-vitamin d3 and exercise on bone structure and strength in older men: an 18-month factorial design randomized controlled trial. J Clin Endocrinol Metab. 2011 Apr; 96(4):955963.

25. Park HS, Joen BJ, Ahn J, Kwak HS. Effects of nanocalcium supplemented milk on bone calcium metabolism in ovariectomized rats. Asian-Aust. J. Anim. Sci. 2007 Aug; 20(8):1266-1271.